Literature DB >> 30455323

Medicare's New Prospective Payment System on Facility Provision of Peritoneal Dialysis.

Virginia Wang1,2,3, Cynthia J Coffman3,4, Linda L Sanders2, Shoou-Yih D Lee5, Richard A Hirth5, Matthew L Maciejewski6,2,3.   

Abstract

BACKGROUND AND OBJECTIVES: Peritoneal dialysis is a self-administered, home-based treatment for ESKD associated with equivalent mortality, higher quality of life, and lower costs compared with hemodialysis. In 2011, Medicare implemented a comprehensive prospective payment system that makes a single payment for all dialysis, medication, and ancillary services. We examined whether the prospective payment system increased dialysis facility provision of peritoneal dialysis services and whether changes in peritoneal dialysis provision were more common among dialysis facilities that are chain affiliated, located in nonurban areas, and in regions with high dialysis market competition. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: We conducted a longitudinal retrospective cohort study of n=6433 United States nonfederal dialysis facilities before (2006-2010) and after (2011-2013) the prospective payment system using data from the US Renal Data System, Medicare, and Area Health Resource Files. The outcomes of interest were a dichotomous indicator of peritoneal dialysis service availability and a discrete count variable of dialysis facility peritoneal dialysis program size defined as the annual number of patients on peritoneal dialysis in a facility. We used general estimating equation models to examine changes in peritoneal dialysis service offerings and peritoneal dialysis program size by a pre- versus post-prospective payment system effect and whether changes differed by chain affiliation, urban location, facility size, or market competition, adjusting for 1-year lagged facility-, patient with ESKD-, and region-level demographic characteristics.
RESULTS: We found a modest increase in observed facility provision of peritoneal dialysis and peritoneal dialysis program size after the prospective payment system (36% and 5.7 patients in 2006 to 42% and 6.9 patients in 2013, respectively). There was a positive association of the prospective payment system with peritoneal dialysis provision (odds ratio, 1.20; 95% confidence interval, 1.13 to 1.18) and PD program size (incidence rate ratio, 1.27; 95% confidence interval, 1.22 to 1.33). Post-prospective payment system change in peritoneal dialysis provision was greater among nonurban (P<0.001), chain-affiliated (P=0.002), and larger-sized facilities (P<0.001), and there were higher rates of peritoneal dialysis program size growth in nonurban facilities (P<0.001).
CONCLUSIONS: Medicare's 2011 prospective payment system was associated with more facilities' availability of peritoneal dialysis and modest growth in facility peritoneal dialysis program size. PODCAST: This article contains a podcast at https://www.asn-online.org/media/podcast/CJASN/2018_11_19_CJASNPodcast_18_12_.mp3.
Copyright © 2018 by the American Society of Nephrology.

Entities:  

Keywords:  ESKD; Health Resources; Incidence; Kidney Failure, Chronic; Medicare; Odds Ratio; Prospective Payment System; Retrospective Studies; dialysis facilities; peritoneal dialysis; policy; quality of life; renal dialysis

Mesh:

Year:  2018        PMID: 30455323      PMCID: PMC6302340          DOI: 10.2215/CJN.05680518

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN: 1555-9041            Impact factor:   8.237


  40 in total

1.  US nephrologists' recommendation of dialysis modality: results of a national survey.

Authors:  M Thamer; W Hwang; N E Fink; J H Sadler; S Wills; N W Levin; E B Bass; A S Levey; R Brookmeyer; N R Powe
Journal:  Am J Kidney Dis       Date:  2000-12       Impact factor: 8.860

Review 2.  Home dialysis in the new USA bundled payment plan: implications and impact.

Authors:  Thomas A Golper; Steven Guest; Joel D Glickman; Joe Turk; Joseph P Pulliam
Journal:  Perit Dial Int       Date:  2011 Jan-Feb       Impact factor: 1.756

3.  Systematic barriers to the effective delivery of home dialysis in the United States: a report from the Public Policy/Advocacy Committee of the North American Chapter of the International Society for Peritoneal Dialysis.

Authors:  Thomas A Golper; Anjali B Saxena; Beth Piraino; Isaac Teitelbaum; John Burkart; Fredric O Finkelstein; Ali Abu-Alfa
Journal:  Am J Kidney Dis       Date:  2011-09-08       Impact factor: 8.860

4.  Home Dialysis in the Prospective Payment System Era.

Authors:  Eugene Lin; Xingxing S Cheng; Kuo-Kai Chin; Talhah Zubair; Glenn M Chertow; Eran Bendavid; Jayanta Bhattacharya
Journal:  J Am Soc Nephrol       Date:  2017-05-10       Impact factor: 10.121

5.  Geographic and temporal trends in peritoneal dialysis services in the United States between 1995 and 2003.

Authors:  Virginia Wang; Shoou-Yih D Lee; Uptal D Patel; Bryan J Weiner; Thomas C Ricketts; Morris Weinberger
Journal:  Am J Kidney Dis       Date:  2010-04-10       Impact factor: 8.860

6.  What do American nephologists think about dialysis modality selection? .

Authors:  D C Mendelssohn; S R Mullaney; B Jung; P G Blake; R L Mehta
Journal:  Am J Kidney Dis       Date:  2001-01       Impact factor: 8.860

7.  Extent and sources of geographic variation in Medicare end-stage renal disease expenditures.

Authors:  R A Hirth; P J Tedeschi; J R Wheeler
Journal:  Am J Kidney Dis       Date:  2001-10       Impact factor: 8.860

8.  Selection bias explains apparent differential mortality between dialysis modalities.

Authors:  Robert R Quinn; Janet E Hux; Matthew J Oliver; Peter C Austin; Marcello Tonelli; Andreas Laupacis
Journal:  J Am Soc Nephrol       Date:  2011-07-22       Impact factor: 10.121

9.  Determinants of modality selection among incident US dialysis patients: results from a national study.

Authors:  Austin G Stack
Journal:  J Am Soc Nephrol       Date:  2002-05       Impact factor: 10.121

10.  Chronic peritoneal dialysis in the United States: declining utilization despite improving outcomes.

Authors:  Rajnish Mehrotra; Dulcie Kermah; Linda Fried; Kamyar Kalantar-Zadeh; Osman Khawar; Keith Norris; Allen Nissenson
Journal:  J Am Soc Nephrol       Date:  2007-09-05       Impact factor: 10.121

View more
  7 in total

1.  Influence of Reimbursement Policies on Dialysis Modality Distribution around the World.

Authors:  Edwina Anne Brown
Journal:  Clin J Am Soc Nephrol       Date:  2018-12-13       Impact factor: 8.237

Review 2.  How To Build a Successful Urgent-Start Peritoneal Dialysis Program.

Authors:  Nilum Rajora; Shani Shastri; Gulzar Pirwani; Ramesh Saxena
Journal:  Kidney360       Date:  2020-08-11

3.  Trends in Dialysis Industry Consolidation After Medicare Payment Reform, 2006-2016.

Authors:  Caroline E Sloan; Abby Hoffman; Matthew L Maciejewski; Cynthia J Coffman; Justin G Trogdon; Virginia Wang
Journal:  JAMA Health Forum       Date:  2021-11-05

4.  Trends in Peritoneal Dialysis Use in the United States after Medicare Payment Reform.

Authors:  Caroline E Sloan; Cynthia J Coffman; Linda L Sanders; Matthew L Maciejewski; Shoou-Yih D Lee; Richard A Hirth; Virginia Wang
Journal:  Clin J Am Soc Nephrol       Date:  2019-11-21       Impact factor: 8.237

5.  Expanded Prospective Payment System and Use of and Outcomes with Home Dialysis by Race and Ethnicity in the United States.

Authors:  Jenny I Shen; Kevin F Erickson; Lucia Chen; Sitaram Vangala; Lynn Leng; Anuja Shah; Anjali B Saxena; Jeffrey Perl; Keith C Norris
Journal:  Clin J Am Soc Nephrol       Date:  2019-07-18       Impact factor: 10.614

6.  Comparing Mortality of Peritoneal and Hemodialysis Patients in an Era of Medicare Payment Reform.

Authors:  Virginia Wang; Cynthia J Coffman; Linda L Sanders; Abby Hoffman; Caroline E Sloan; Shoou-Yih D Lee; Richard A Hirth; Matthew L Maciejewski
Journal:  Med Care       Date:  2021-02-01       Impact factor: 3.178

Review 7.  The current and future landscape of dialysis.

Authors:  Jonathan Himmelfarb; Raymond Vanholder; Rajnish Mehrotra; Marcello Tonelli
Journal:  Nat Rev Nephrol       Date:  2020-07-30       Impact factor: 28.314

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.